CT-721 structure
|
Common Name | CT-721 | ||
---|---|---|---|---|
CAS Number | 1388710-60-8 | Molecular Weight | 525.04 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C30H29ClN6O | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of CT-721CT-721 is a potent and time-dependent Bcr-Abl kinase inhibitor with an IC50 of 21.3 nM for wild-type Bcr-Abl kinase, and possesses anti-chronic myeloid leukemia (CML) activities[1]. |
Name | CT-721 |
---|
Description | CT-721 is a potent and time-dependent Bcr-Abl kinase inhibitor with an IC50 of 21.3 nM for wild-type Bcr-Abl kinase, and possesses anti-chronic myeloid leukemia (CML) activities[1]. |
---|---|
Related Catalog | |
Target |
IC50: 21.3 nM (wild-type Bcr-Abl kinase)[1] |
References |
Molecular Formula | C30H29ClN6O |
---|---|
Molecular Weight | 525.04 |
Hazard Codes | Xi |
---|